Navigation Links
Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
Date:1/30/2013

ALISO VIEJO, Calif., Jan. 30, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2012 after market close on Thursday February 7, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (866) 783-2141
International callers: +1 (857) 350-1600
Passcode: 51423033

Webcast information: Visit http://www.avanir.com.

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 87153907.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
2. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
3. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
4. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
5. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
6. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
7. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
8. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
9. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
10. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
11. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... 2016 Global  urinalysis market ... by 2022, according to a new report by ... http://photos.prnewswire.com/prnh/20150105/723757 ) , Automation ... and accuracy delivered by the new generation urinalysis ... urinalysis instruments and consumables. For instance, the automatic ...
(Date:4/26/2016)... April 26, 2016 Diplomat Pharmacy, Inc. (NYSE: ... Jennifer Hagerman , Pharm D., to Vice President of ... at Diplomat, Hagerman will continue to lead and oversee ... delivers custom education and training to Diplomat employees and ... industry. Diplomat University also houses the quality assurance department, ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... A new study by a ... diaphragmatic hernia have better survival rates if surgery is performed early. Approximately one ... the diaphragm fails to form completely, letting abdominal organs into the chest cavity ...
(Date:4/29/2016)... ... 29, 2016 , ... The Wharton School of the ... Prize of the 2016 Wharton Business Plan Competition —as well as the ... and the Committee Award for Most ‘Wow Factor,’ making them the first team ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent ... cancer deaths. More than 10,000 people are expected to die of melanoma this year. The ... the one of the most commonly diagnosed cancers in young women. A recent breakthrough in ...
(Date:4/29/2016)... ... ... City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert in ... apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer from ... bones. This surgery is performed to correct the alignment of the jaw. It is beneficial ...
Breaking Medicine News(10 mins):